Autopsy report · NCT00000430
Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis
Cause of deathNo reason given
Life of this trial
- Registered 3 months after it had already started.
- Ran for about 4 years 11 months before it stopped.
- 240 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Sponsor type
- US National Institutes of Health
- Conditions
- Osteopenia; Osteoporosis
- Interventions
- Alendronate; Estrogen/progestin therapy
- Participants
- 240
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.